AN2 Therapeutics, Inc. (ANTX) Dividend Yield, History & Forecast
AN2 Therapeutics, Inc. (ANTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. The most recent ex-dividend date was January 11, 2018. market capitalization is approximately $90M.
Frequently Asked Questions about AN2 Therapeutics, Inc. (ANTX)
When does AN2 Therapeutics, Inc. pay its next dividend?▾
The most recent ex-dividend date was January 11, 2018.
Is AN2 Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is AN2 Therapeutics, Inc. in?▾
AN2 Therapeutics, Inc. (ANTX) operates in the Healthcare sector, specifically the Biotechnology industry.
